Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on mRNA Drug market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
mRNA Drug Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
mRNA Drug Market by Type [Analysis by Value from 2020 to ]:
- Vaccines
- Therapeutics
- Personalized Medicine
- Cancer Immunotherapy
mRNA Drug Market by Application [Analysis by Value from 2020 to ]:
- Infectious Diseases
- Oncology
- Rare Diseases
- Autoimmune Disorders
Key Players in the mRNA Drug Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- Moderna
- BioNTech
- Pfizer
- CureVac
- Sanofi
- GSK
- AstraZeneca
- Merck
- Translate Bio
- Arcturus Therapeutics
- eTheRNA
- Kernal Biologics
- Acuitas Therapeutics
- RNAimmune
- Replicate Bioscience
- Tiba Biotech
- Strand Therapeutics
- GreenLight Biosciences
- HDT Bio
- Daiichi Sankyo
mRNA Drug Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
mRNA Drug Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
mRNA Drug Market Size & Demand Forecast ()
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
mRNA Drug Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
mRNA Drug Segmentation & Growth Forecasts
The study systematically breaks down the Global mRNA Drug Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This mRNA Drug Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the mRNA Drug market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 mRNA Drug Definition
1.2 Global mRNA Drug Market Size and Forecast
1.2.1 By Revenue, Global mRNA Drug Market Size, 2019-2030
1.2.2 By Sales Volume, Global mRNA Drug Market Size, 2019-2030
1.2.3 Global mRNA Drug Price Trend, 2019-2030
1.3 China mRNA Drug Market Size and Forecast
1.3.1 By Revenue, China mRNA Drug Market Size, 2019-2030
1.3.2 By Sales Volume, China mRNA Drug Market Size, 2019-2030
1.3.3 China mRNA Drug Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China mRNA Drug Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China mRNA Drug Share in Global Market, 2019-2030
1.4.3 mRNA Drug Market Size: China VS Global, 2019-2030
1.5 mRNA Drug Market Dynamics
1.5.1 mRNA Drug Market Drivers
1.5.2 mRNA Drug Market Restraints
1.5.3 mRNA Drug Industry Trends
1.5.4 mRNA Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global mRNA Drug Revenue by Company, 2019-2024
2.2 Global mRNA Drug Sales Volume by Company, 2019-2024
2.3 Global mRNA Drug Price by Company, 2019-2024
2.4 Global mRNA Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global mRNA Drug Concentration Ratio
2.6 Global mRNA Drug Mergers & Acquisitions, Expansion Plans
2.7 Global mRNA Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China mRNA Drug Revenue by Company, 2019-2024
3.2 China mRNA Drug Sales Volume by Company, 2019-2024
3.3 China mRNA Drug mRNA Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China mRNA Drug Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, mRNA Drug Domestic VS Export
3.6 China Market, mRNA Drug Import & Export
3.6.1 China Market, mRNA Drug Import & Export, 2019-2030
3.6.2 China mRNA Drug Import & Export Trends
3.6.3 Main Sources of China mRNA Drug Import
3.6.4 Export Destination of China mRNA Drug
4 mRNA Drug Production by Region
4.1 Global mRNA Drug Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of mRNA Drug Manufacturers
4.3 Global Major Manufacturers, mRNA Drug Capacity Expansion and Future Plans
4.4 Global mRNA Drug Capacity by Region
4.5 Global mRNA Drug Production by Region
4.5.1 Global mRNA Drug Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global mRNA Drug Production by Region, 2019-2024
4.5.3 Global mRNA Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 mRNA Drug Industry Chain
5.2 mRNA Drug Upstream Analysis
5.2.1 mRNA Drug Core Raw Materials
5.2.2 Main Manufacturers of mRNA Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 mRNA Drug Production Mode
5.6 mRNA Drug Procurement Model
5.7 mRNA Drug Industry Sales Model and Sales Channels
5.7.1 mRNA Drug Sales Model
5.7.2 mRNA Drug Typical Distributors
6 Sights by Type
6.1 mRNA Drug Classification
6.1.1 Preventive Vaccines
6.1.2 Therapeutic Vaccine
6.1.3 Therapeutic Drugs
6.2 By Type, Global mRNA Drug Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global mRNA Drug Revenue, 2019-2030
6.4 By Type, Global mRNA Drug Sales Volume, 2019-2030
6.5 By Type, Global mRNA Drug Price, 2019-2030
7 Sights by Application
7.1 mRNA Drug Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global mRNA Drug Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global mRNA Drug Revenue, 2019-2030
7.4 By Application, Global mRNA Drug Sales Volume, 2019-2030
7.5 By Application, Global mRNA Drug Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global mRNA Drug Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global mRNA Drug Revenue, 2019-2030
8.3 By Region, Global mRNA Drug Sales Volume, 2019-2030
8.4 North America
8.4.1 North America mRNA Drug Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America mRNA Drug Market Size Market Share
8.5 Europe
8.5.1 Europe mRNA Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe mRNA Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific mRNA Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific mRNA Drug Market Size Market Share
8.7 South America
8.7.1 South America mRNA Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America mRNA Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global mRNA Drug Market Size & CAGR,2019 VS 2024 VS 2030
9.2 By Country, Global mRNA Drug Revenue, 2019-2030
9.3 By Country, Global mRNA Drug Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. mRNA Drug Market Size, 2019-2030
9.4.2 By Company, U.S. mRNA Drug Sales Volume Market Share, 2024
9.4.3 By Type, U.S. mRNA Drug Market Size, Share, 2024 VS 2030
9.4.4 By Application, U.S. mRNA Drug Market Size, Share, 2024 VS 2030
9.5 Europe
9.5.1 Europe mRNA Drug Market Size, 2019-2030
9.5.2 By Company, Europe mRNA Drug Sales Volume Market Share, 2024
9.5.3 By Type, Europe mRNA Drug Market Size, Share, 2024 VS 2030
9.5.4 By Application, Europe mRNA Drug Market Size, Share, 2024 VS 2030
9.6 China
9.6.1 China mRNA Drug Market Size, 2019-2030
9.6.2 By Company, China mRNA Drug Sales Volume Market Share, 2024
9.6.3 By Type, China mRNA Drug Market Size, Share, 2024 VS 2030
9.6.4 By Application, China mRNA Drug Market Size, Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan mRNA Drug Market Size, 2019-2030
9.7.2 By Company, Japan mRNA Drug Sales Volume Market Share, 2024
9.7.3 By Type, Japan mRNA Drug Market Size, Share, 2024 VS 2030
9.7.4 By Application, Japan mRNA Drug Market Size, Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea mRNA Drug Market Size, 2019-2030
9.8.2 By Company, South Korea mRNA Drug Sales Volume Market Share, 2024
9.8.3 By Type, South Korea mRNA Drug Market Size, Share, 2024 VS 2030
9.8.4 By Application, South Korea mRNA Drug Market Size, Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia mRNA Drug Market Size, 2019-2030
9.9.2 By Company, Southeast Asia mRNA Drug Sales Volume Market Share, 2024
9.9.3 By Type, Southeast Asia mRNA Drug Market Size, Share, 2024 VS 2030
9.9.4 By Application, Southeast Asia mRNA Drug Market Size, Share, 2024 VS 2030
9.10 India
9.10.1 India mRNA Drug Market Size, 2019-2030
9.10.2 By Company, India mRNA Drug Sales Volume Market Share, 2024
9.10.3 By Type, India mRNA Drug Market Size, Share, 2024 VS 2030
9.10.4 By Application, India mRNA Drug Market Size, Share, 2024 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia mRNA Drug Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia mRNA Drug Sales Volume Market Share, 2024
9.11.3 By Type, Middle East & Asia mRNA Drug Market Size, Share, 2024 VS 2030
9.11.4 By Application, Middle East & Asia mRNA Drug Market Size, Share, 2024 VS 2030
10 Manufacturers Profile
10.1 Moderna
10.1.1 Moderna Company Information, Head Office, Market Area and Industry Position
10.1.2 Moderna mRNA Drug Models, Specifications and Application
10.1.3 Moderna mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Moderna Company Profile and Main Business
10.1.5 Moderna Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.2.2 Pfizer mRNA Drug Models, Specifications and Application
10.2.3 Pfizer mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 Zydus Cadila
10.3.1 Zydus Cadila Company Information, Head Office, Market Area and Industry Position
10.3.2 Zydus Cadila mRNA Drug Models, Specifications and Application
10.3.3 Zydus Cadila mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Zydus Cadila Company Profile and Main Business
10.3.5 Zydus Cadila Recent Developments
10.4 Fosun Pharma
10.4.1 Fosun Pharma Company Information, Head Office, Market Area and Industry Position
10.4.2 Fosun Pharma mRNA Drug Models, Specifications and Application
10.4.3 Fosun Pharma mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Fosun Pharma Company Profile and Main Business
10.4.5 Fosun Pharma Recent Developments
10.5 CureVAC
10.5.1 CureVAC Company Information, Head Office, Market Area and Industry Position
10.5.2 CureVAC mRNA Drug Models, Specifications and Application
10.5.3 CureVAC mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 CureVAC Company Profile and Main Business
10.5.5 CureVAC Recent Developments
10.6 Sri Lankan Microorganisms
10.6.1 Sri Lankan Microorganisms Company Information, Head Office, Market Area and Industry Position
10.6.2 Sri Lankan Microorganisms mRNA Drug Models, Specifications and Application
10.6.3 Sri Lankan Microorganisms mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Sri Lankan Microorganisms Company Profile and Main Business
10.6.5 Sri Lankan Microorganisms Recent Developments
10.7 BioNtech
10.7.1 BioNtech Company Information, Head Office, Market Area and Industry Position
10.7.2 BioNtech mRNA Drug Models, Specifications and Application
10.7.3 BioNtech mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 BioNtech Company Profile and Main Business
10.7.5 BioNtech Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.8.2 AstraZeneca mRNA Drug Models, Specifications and Application
10.8.3 AstraZeneca mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 AstraZeneca Company Profile and Main Business
10.8.5 AstraZeneca Recent Developments
10.9 Janssen
10.9.1 Janssen Company Information, Head Office, Market Area and Industry Position
10.9.2 Janssen mRNA Drug Models, Specifications and Application
10.9.3 Janssen mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Janssen Company Profile and Main Business
10.9.5 Janssen Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. mRNA Drug Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. mRNA Drug Market Restraints
Table 3. mRNA Drug Market Trends
Table 4. mRNA Drug Industry Policy
Table 5. Global mRNA Drug Revenue by Company, 2019-2024, US$ million
Table 6. Global mRNA Drug Revenue Market Share by Company, 2019-2024
Table 7. Global mRNA Drug Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global mRNA Drug Sales Volume Market Share by Company, 2019-2024
Table 9. Global mRNA Drug Price by Company, 2019-2024, (US$/Unit)
Table 10. Global mRNA Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global mRNA Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global mRNA Drug Manufacturers Product Type
Table 13. China mRNA Drug Revenue by Company, 2019-2024, US$ million
Table 14. China mRNA Drug Revenue Market Share by Company, 2019-2024
Table 15. China mRNA Drug Sales Volume by Company, 2019-2024, (K Units)
Table 16. China mRNA Drug Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, mRNA Drug Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China mRNA Drug Import & Export Trends
Table 19. Main Sources of China mRNA Drug Import
Table 20. Export Destination of China mRNA Drug
Table 21. Global Headquarters and Manufacturing Base of mRNA Drug Manufacturers
Table 22. Global Major Manufacturers, mRNA Drug Capacity Expansion and Future Plans
Table 23. Global mRNA Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global mRNA Drug Production by Region, 2019-2024, (K Units)
Table 25. Global mRNA Drug Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of mRNA Drug Upstream (Raw Materials)
Table 27. Global mRNA Drug Typical Customers
Table 28. mRNA Drug Typical Distributors
Table 29. By Type, Global mRNA Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global mRNA Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global mRNA Drug Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global mRNA Drug Revenue, 2019-2030, US$ Million
Table 33. By Region, Global mRNA Drug Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global mRNA Drug Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global mRNA Drug Revenue, 2019-2030, US$ Million
Table 36. By Country, Global mRNA Drug Revenue Market Share, 2019-2030
Table 37. By Country, Global mRNA Drug Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global mRNA Drug Sales Volume Market Share, 2019-2030
Table 39. Moderna Company Information, Head Office, Market Area and Industry Position
Table 40. Moderna mRNA Drug Models, Specifications and Application
Table 41. Moderna mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Moderna Company Profile and Main Business
Table 43. Moderna Recent Developments
Table 44. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 45. Pfizer mRNA Drug Models, Specifications and Application
Table 46. Pfizer mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Pfizer Company Profile and Main Business
Table 48. Pfizer Recent Developments
Table 49. Zydus Cadila Company Information, Head Office, Market Area and Industry Position
Table 50. Zydus Cadila mRNA Drug Models, Specifications and Application
Table 51. Zydus Cadila mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Zydus Cadila Company Profile and Main Business
Table 53. Zydus Cadila Recent Developments
Table 54. Fosun Pharma Company Information, Head Office, Market Area and Industry Position
Table 55. Fosun Pharma mRNA Drug Models, Specifications and Application
Table 56. Fosun Pharma mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Fosun Pharma Company Profile and Main Business
Table 58. Fosun Pharma Recent Developments
Table 59. CureVAC Company Information, Head Office, Market Area and Industry Position
Table 60. CureVAC mRNA Drug Models, Specifications and Application
Table 61. CureVAC mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. CureVAC Company Profile and Main Business
Table 63. CureVAC Recent Developments
Table 64. Sri Lankan Microorganisms Company Information, Head Office, Market Area and Industry Position
Table 65. Sri Lankan Microorganisms mRNA Drug Models, Specifications and Application
Table 66. Sri Lankan Microorganisms mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Sri Lankan Microorganisms Company Profile and Main Business
Table 68. Sri Lankan Microorganisms Recent Developments
Table 69. BioNtech Company Information, Head Office, Market Area and Industry Position
Table 70. BioNtech mRNA Drug Models, Specifications and Application
Table 71. BioNtech mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. BioNtech Company Profile and Main Business
Table 73. BioNtech Recent Developments
Table 74. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 75. AstraZeneca mRNA Drug Models, Specifications and Application
Table 76. AstraZeneca mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. AstraZeneca Company Profile and Main Business
Table 78. AstraZeneca Recent Developments
Table 79. Janssen Company Information, Head Office, Market Area and Industry Position
Table 80. Janssen mRNA Drug Models, Specifications and Application
Table 81. Janssen mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Janssen Company Profile and Main Business
Table 83. Janssen Recent Developments
List of Figure
Figure 1. mRNA Drug Picture
Figure 2. By Revenue, Global mRNA Drug Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global mRNA Drug Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global mRNA Drug Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China mRNA Drug Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China mRNA Drug Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China mRNA Drug Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China mRNA Drug Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China mRNA Drug Share of Global Market, 2019-2030
Figure 10. Global mRNA Drug Key Participants, Market Share, 2021 VS 2024 VS 2023
Figure 11. Global mRNA Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2024
Figure 12. China mRNA Drug Key Participants, Market Share, 2021 VS 2024 VS 2023
Figure 13. China mRNA Drug Key Participants, Market Share, 2021 VS 2024 VS 2023
Figure 14. China mRNA Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of mRNA Drug Domestic VS Export, 2024
Figure 16. Global mRNA Drug Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global mRNA Drug Capacity Market Share by Region, 2024 VS 2030
Figure 18. Global mRNA Drug Production Market Share & Forecast by Region, 2019-2030
Figure 19. mRNA Drug Industry Chain
Figure 20. mRNA Drug Procurement Model
Figure 21. mRNA Drug Sales Model
Figure 22. mRNA Drug Sales Channels, Direct Sales and Distribution
Figure 23. Preventive Vaccines
Figure 24. Therapeutic Vaccine
Figure 25. Therapeutic Drugs
Figure 26. By Type, Global mRNA Drug Revenue, 2019-2030, US$ Million
Figure 27. By Type, Global mRNA Drug Revenue Market Share, 2019-2030
Figure 28. By Type, Global mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 29. By Type, Global mRNA Drug Sales Volume Market Share, 2019-2030
Figure 30. By Type, Global mRNA Drug Price, 2019-2030, (US$/Unit)
Figure 31. Hospital
Figure 32. Clinic
Figure 33. By Application, Global mRNA Drug Revenue, 2019-2030, US$ Million
Figure 34. By Application, Global mRNA Drug Revenue Market Share, 2019-2030
Figure 35. By Application, Global mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 36. By Application, Global mRNA Drug Sales Volume Market Share, 2019-2030
Figure 37. By Application, Global mRNA Drug Price, 2019-2030, (US$/Unit)
Figure 38. By Region, Global mRNA Drug Revenue Market Share, 2019-2030
Figure 39. By Region, Global mRNA Drug Sales Volume Market Share, 2019-2030
Figure 40. North America mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 41. By Country, North America mRNA Drug Revenue Market Share, 2024
Figure 42. Europe mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, Europe mRNA Drug Revenue Market Share, 2024
Figure 44. Asia Pacific mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country/Region, Asia Pacific mRNA Drug Revenue Market Share, 2024
Figure 46. South America mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, South America mRNA Drug Revenue Market Share, 2024
Figure 48. Middle East & Africa mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. U.S. mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 50. By Company, U.S. mRNA Drug Market Share, 2024
Figure 51. By Type, U.S. mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 52. By Application, U.S. mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 53. Europe mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, Europe mRNA Drug Market Share, 2024
Figure 55. By Type, Europe mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 56. By Application, Europe mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 57. China mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, China mRNA Drug Market Share, 2024
Figure 59. By Type, China mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 60. By Application, China mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 61. Japan mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, Japan mRNA Drug Market Share, 2024
Figure 63. By Type, Japan mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 64. By Application, Japan mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 65. South Korea mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, South Korea mRNA Drug Market Share, 2024
Figure 67. By Type, South Korea mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 68. By Application, South Korea mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 69. Southeast Asia mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, Southeast Asia mRNA Drug Market Share, 2024
Figure 71. By Type, Southeast Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 72. By Application, Southeast Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 73. India mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, India mRNA Drug Market Share, 2024
Figure 75. By Type, India mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 76. By Application, India mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 77. Middle East & Asia mRNA Drug Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, Middle East & Asia mRNA Drug Market Share, 2024
Figure 79. By Type, Middle East & Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 80. By Application, Middle East & Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Research Methodology:
mRNA Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|